Metabolic Peptides
GLP-1, GIP and amylin receptor agonists and related metabolic compounds for receptor-level research.
Our metabolic collection covers the most studied metabolic peptides available for research, from GLP-1 and dual GIP/GLP-1 receptor agonists to lipolytic growth-hormone fragments. Each compound is selected for documented mechanism, purity, and relevance to appetite, glucose-handling, and fat-metabolism research.
Showing 11 products
5-Amino-1MQ
5-Amino-1MQ is a small-molecule NNMT inhibitor that raises NAD+ and SAM to support fat-cell metabolism, insulin sensitivity and healthy aging research.
AOD-9604
AOD9604 (Anti-Obesity Drug 9604) is a synthetic fragment of human growth hormone (HGH) that targets fat metabolism without raising IGF-1.
Cagrilintide
Cagrilintide is a long-acting amylin analogue for once-weekly research use, studied for satiety signalling alone and combined with semaglutide.
L-Carnitine
L-Carnitine (levocarnitine) is an amino-acid derivative that transports long-chain fatty acids into the mitochondrion for beta-oxidation.
MOTS-c
MOTS-c is a mitochondrial-derived peptide encoded in mitochondrial DNA that activates AMPK and is studied as an exercise mimetic for metabolic regulation.
Retatrutide
Retatrutide (LY3437943) is an investigational peptide binding the GLP-1, GIP and glucagon receptors. Research compound, not an approved medicine.
Semaglutide
Semaglutide is a 31-amino-acid GLP-1 receptor agonist peptide with C18 fatty-acid acylation. Research compound, supplied as lyophilised powder.
SLU-PP-332
SLU-PP-332 is an estrogen-related receptor (ERR) pan-agonist studied as an exercise mimetic that boosts mitochondrial activity and fat oxidation.
Tesamorelin
Tesamorelin is a synthetic GHRH(1-44) analogue with an N-terminal trans-3-hexenoyl group that resists DPP-4 cleavage. Research compound.
Tesofensine
Tesofensine (NS2330) is an orally available triple monoamine reuptake inhibitor at the DAT, NET and SERT transporters. Research compound.
Tirzepatide
Tirzepatide is a 39-amino-acid peptide with dual agonist activity at the GIP and GLP-1 receptors. Research compound, supplied as lyophilised powder.
Understanding metabolic and weight-management peptides
Incretin-mimetic peptides such as semaglutide, tirzepatide, and retatrutide act on the GLP-1, GIP, and glucagon receptor systems that regulate metabolic signalling, gastric emptying, and insulin response. Fragment peptides like AOD-9604 and tesofensine are studied along separate lipolytic and monoamine pathways. Together they make this one of the most active areas in current metabolic research.
Research applications
These compounds are widely used in laboratory study of energy balance, glycemic control, and body-composition models. Researchers select between single-receptor agonists and the newer multi-receptor candidates depending on the pathway under investigation. Reported potencies vary considerably between molecules, which is why mechanism and half-life are documented on every product page.
Quality, documentation and dispatch
Every weight-management peptide at Milo-Lab is supplied at pharmaceutical-grade purity with quality documentation, and is intended strictly for laboratory and research use. We ship discreetly from Thailand with secure worldwide dispatch. Orders are placed directly on the site and paid by card or cryptocurrency, and every shipment goes out with a tracking number.
All products are supplied strictly for laboratory and research purposes and are not intended for human consumption.